TY - JOUR
T1 - Development of the PSU Child Pump
AU - Scheib, Christopher
AU - Newswanger, Raymond
AU - Cysyk, Joshua
AU - Bohnenberger, Karl
AU - Lukic, Branka
AU - Xu, Lichong
AU - Yeager, Eric
AU - Bletcher, Kirby
AU - Leibich, Patrick
AU - Jackson, Quandashia
AU - Flory, Heidi
AU - Tillinger, Mindy
AU - Weiss, William
AU - Rosenberg, Gerson
AU - Jhun, Choon Sik
N1 - Publisher Copyright:
© ASAIO 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - The Pennsylvania State University (PSU) Child Pump, a centrifugal continuous-flow ventricular assist device (cf-VAD), is being developed as a suitable long-term implantable device for pediatric heart failure patients between 10 and 35 kg, body surface area (BSA) of 0.5-1.2 m2, 1-11 years of age, and requiring a mean cardiac output of 1.0-3.5 L/min. In-vitro hydraulic and hemodynamic performances were evaluated on a custom mock circulatory loop with ovine blood. Normalized index of hemolysis (NIH) was evaluated under four conditions: 1) 8,300 rpm, 3.5 L/min, ΔP = 60 mm Hg, 2) 8,150 rpm, 5.1 L/min, ΔP = 20 mm Hg, 3) 8,400 rpm, 3.2 L/min, ΔP = 70 mm Hg, and 4) 9,850 rpm, 5.0 L/min, ΔP = 80 mm Hg, resulting in normalized index of hemolysis = 0.027 ± 0.013, 0.015 ± 0.006, 0.016 ± 0.008, and 0.026 ± 0.011 mg/dl, respectively. A mock fit study was conducted using a three-dimensional printed model of a 19 kg patient's thoracic cavity to compare the size of the PSU Child Pump to the HeartMate3 and the HVAD. Results indicate the PSU Child Pump will be a safer, appropriately sized device capable of providing the given patient cohort proper support while minimizing the risks of blood trauma as they wait for a transplant.
AB - The Pennsylvania State University (PSU) Child Pump, a centrifugal continuous-flow ventricular assist device (cf-VAD), is being developed as a suitable long-term implantable device for pediatric heart failure patients between 10 and 35 kg, body surface area (BSA) of 0.5-1.2 m2, 1-11 years of age, and requiring a mean cardiac output of 1.0-3.5 L/min. In-vitro hydraulic and hemodynamic performances were evaluated on a custom mock circulatory loop with ovine blood. Normalized index of hemolysis (NIH) was evaluated under four conditions: 1) 8,300 rpm, 3.5 L/min, ΔP = 60 mm Hg, 2) 8,150 rpm, 5.1 L/min, ΔP = 20 mm Hg, 3) 8,400 rpm, 3.2 L/min, ΔP = 70 mm Hg, and 4) 9,850 rpm, 5.0 L/min, ΔP = 80 mm Hg, resulting in normalized index of hemolysis = 0.027 ± 0.013, 0.015 ± 0.006, 0.016 ± 0.008, and 0.026 ± 0.011 mg/dl, respectively. A mock fit study was conducted using a three-dimensional printed model of a 19 kg patient's thoracic cavity to compare the size of the PSU Child Pump to the HeartMate3 and the HVAD. Results indicate the PSU Child Pump will be a safer, appropriately sized device capable of providing the given patient cohort proper support while minimizing the risks of blood trauma as they wait for a transplant.
UR - http://www.scopus.com/inward/record.url?scp=85205404559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85205404559&partnerID=8YFLogxK
U2 - 10.1097/MAT.0000000000002202
DO - 10.1097/MAT.0000000000002202
M3 - Article
C2 - 38537074
AN - SCOPUS:85205404559
SN - 1058-2916
VL - 70
SP - 892
EP - 897
JO - ASAIO Journal
JF - ASAIO Journal
IS - 10
ER -